BP’s Bioverativ Inc. Common Stock BIVV Stock Holding History

BP’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-14,000	Closed	-$755K	–	472
2017 Q4	$755K	Hold	14,000	–	–	0.03%	423
2017 Q3	$799K	Hold	14,000	–	–	0.03%	409
2017 Q2	$842K	Hold	14,000	–	–	0.03%	381
2017 Q1	$762K	Buy	+14,000	New	+$690K	0.03%	380

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

BP's BIVV Position: Q1 2018 in Review

BP sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 14,000 shares — an estimated $755K sold.

BP first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $842K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

BP reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
BP sold 14,000 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $755K.
BP first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
BP's Bioverativ Inc. Common Stock position peaked at $842K in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on BP's 13F filing for Q1 2018, filed 26 Apr 2018.